MedTrace Logo

Advanced Methods for Cancer Detection by Vaginal Screening

NCT02622776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2019-03-06

No results posted yet for this study

Summary

This pilot study is the first step in the development of an new assay that may be further tested as a screening method for ovarian and endometrial cancers.

Conditions

Interventions

OTHER

Vaginal DNA Collection

Vaginal self-swab, 6hr tampon collection and response to an acceptability questionnaire

Sponsors & Collaborators

  • Anna Tinker

    lead OTHER

Principal Investigators

  • Anna Tinker, MD · British Columbia Cancer Agency

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02622776 on ClinicalTrials.gov